Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500487 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Wen Shao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First A…. Hauptthemen laut MEDLINE: Ferroptosis, Indoles, Antioxidants. Die Arbeit nennt 36 Literaturangaben. Gefördert von: The Guangdong Basic and Applied Basic Research Foundation, The National Natural Science Foundation of China, The China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Ferroptosis, a form of regulated cell death characterized by excessive lipid peroxidation, has been implicated in various neurological disorders. Ferrostatin‐1 (Fer‐1), a well‐known ferroptosis inhibitor, exhibits therapeutic potential but suffers from poor metabolic stability, limiting its applications. In this study, a phenotype‐based screening of an in‐house compound library is conducted and a novel ferroptosis inhibitor, TJC‐2‐1 , is identified. To optimize its inhibitory activity, a series of 35 indoline derivatives are synthesized and evaluated. Among them, compound 14 exhibits the most potent inhibition against erastin‐induced (EC 50 = 0.15 μM) and RSL3‐induced (EC 50 = 0.15 μM) ferroptosis in HT22 mouse hippocampal cells. Mechanistic investigations reveal that compound 14 functions as a novel radical‐trapping antioxidant, exhibiting lipid peroxidation scavenging capacity comparable to that of Fer‐1. Remarkably, compound 14 demonstrates significantly improved microsomal metabolic stability compared to Fer‐1. These findings suggest that compound 14 has the potential to serve as a lead compound for ferroptosis‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, C…
- University of South China, Hengyang, 421001, China.
- Innovative Center for Pathogen Research, Guangzhou National Laboratory, Guangzhou, 510005, China.
ORCID-Profile: Yuying Fang
Förderung
- The Guangdong Basic and Applied Basic Research Foundation
- The National Natural Science Foundation of China
- The China Postdoctoral Science Foundation
- The R&D Program of Guangzhou National Laboratory
Zitieren
APA
Shao, W., Liu, Y., Jiang, D., Xing, Z., Qiao, J., Liu, M., Huang, X., Zhang, R., Fang, Y., & Peng, W. (2025). Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. https://doi.org/10.1002/cmdc.202500487
Vancouver
Shao W, Liu Y, Jiang D, Xing Z, Qiao J, Liu M, et al. Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. 2025. doi:10.1002/cmdc.202500487
BibTeX
@article{Shao2025,
author = {Shao, Wen and Liu, Yuanyuan and Jiang, Deling and Xing, Zhiyang and Qiao, Jiale and Liu, Man and Huang, Xupeng and Zhang, Renyu and Fang, Yuying and Peng, Wei},
title = {Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500487}
}
EUVIMED